Mark Greenwald to Angiogenesis Inhibitors
This is a "connection" page, showing publications Mark Greenwald has written about Angiogenesis Inhibitors.
Connection Strength
0.819
-
PROPHYLACTIC PERIPHERAL LASER AND FLUORESCEIN ANGIOGRAPHY AFTER BEVACIZUMAB FOR RETINOPATHY OF PREMATURITY. Retina. 2018 Apr; 38(4):764-772.
Score: 0.533
-
Neurodevelopmental Outcomes Comparing Bevacizumab to Laser for Type 1 ROP. Ophthalmic Surg Lasers Imaging Retina. 2019 06 01; 50(6):337-343.
Score: 0.144
-
Refractive outcomes comparing primary laser to primary bevacizumab with delayed laser for type 1 ROP. J AAPOS. 2019 04; 23(2):88.e1-88.e6.
Score: 0.142